Cargando…
Restarting anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation: A nationwide retrospective cohort study
BACKGROUND: Resuming anticoagulation after an intracranial hemorrhage (ICH) poses a clinical conundrum. The absence of relevant guidelines has led to wide variations in the decision on resuming anticoagulation therapies after ICH. This study aimed to evaluate the risks of an anticoagulation therapy...
Autores principales: | Moon, Jong Youn, Bae, Gi Hwan, Jung, Jaehun, Shin, Dong Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152296/ https://www.ncbi.nlm.nih.gov/pubmed/35655532 http://dx.doi.org/10.1016/j.ijcha.2022.101037 |
Ejemplares similares
-
Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage
por: Wu, Victor Chien-Chia, et al.
Publicado: (2021) -
Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
por: Perreault, Sylvie, et al.
Publicado: (2019) -
Management of oral anticoagulant therapy after intracranial hemorrhage in patients with atrial fibrillation
por: Lucà, Fabiana, et al.
Publicado: (2023) -
Anticoagulation Holiday: Resumption of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Index Traumatic Intracranial Hemorrhage
por: Ghenbot, Yohannes, et al.
Publicado: (2022) -
Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?
por: Burth, Sina, et al.
Publicado: (2021)